课题基金 / 基金详情

CSHL 2023 Conference on Telomeres & Telomerase

CSHL 2023 Conference on Telomeres & Telomerase
CSHL 2023端粒会议
批准号:
10671999
负责人:
DAVID J. STEWART
金额:
$3.1万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-04-01 至 2024-03-31

项目摘要

项目成果

DAVID J. STEWART的其他基金

相似基金

相关文献

中文摘要
翻译
冷泉港实验室端粒和端粒酶会议
英文摘要
Cold Spring Harbor Laboratory Conference on Telomeres and Telomerase May 2–6, 2023 Abstract Telomeres are specialized protein-nucleic acid complexes that protect the ends of eukaryotic chromosomes. In most eukaryotes, telomeres contain short DNA repeats that are maintained by the telomerase reverse transcriptase. It has long been recognized that age and replication-associated telomere shortening is a driver of the cellular and organismal aging process, and that telomere length and integrity are regulators of human life span. Short or dysfunctional telomeres drive cells into senescence or cell death and are causative for numerous age-associated pathologies in humans, ranging from stem cell dysfunction, cognitive disorders and dementia to the age dependent increase in cancer risk. Mutations in telomere and telomerase components causing accelerated telomere shortening, such as observed in Dyskeratosis Congenita are directly associate with age- associated disorders and reduced lifespan, emphasizing the importance of understanding telomere function for the human health span and prevention of age-associated pathologies. As a result, the telomere field is now highly diverse and dynamic, representing a wide variety of research areas in which telomeres play crucial roles (aging, telomere syndromes, stem cells, cell cycle progression, cancer, meiosis and fertility, recombination, replication). The field encompasses research with mouse and human systems as well as insights gained from a wide variety of different model organisms (birds, frogs, flies, plants, nematodes, protozoa, budding yeast, fission yeast). This meeting focuses on understanding the interplay of telomeric proteins with cellular pathways that regulate genome integrity, on progress in the fields of telomerase regulation and biogenesis, on the regulation of aging and immortality by telomere maintenance pathways and on telomere dependent pathologies as function of telomere length, integrity and organismal age. The previous twelve Cold Spring Harbor Laboratory meetings on Telomeres and Telomerase have been crucial in bringing together a diverse group of researchers from all parts of the world, and have resulted in vigorous discussion and synergistic interactions stimulated by the presentation of mostly unpublished data. Because the CSHL Telomeres and Telomerase conference remains the only opportunity for scientists in this rapidly growing field to interact as a whole, this meeting is unique and of the utmost importance for the future of the field. Moreover, the format of CSHL meetings, for which nearly all talks are chosen from submitted abstracts, maximizes the opportunity for new independent investigators, postdocs and graduate students to present their work in a highly visible venue. These meetings have all had a uniformly high attendance rate from an international group of researchers, and the podium and posters have consistently presented the major discoveries in the field well before publication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSHL Single Cell Analysis Course (2023-2027)
  • 批准号:
    10627446
  • 项目类别:
  • 资助金额:
    $16.16万
  • 财政年份:
    2023
  • 负责人:
    DAVID J. STEWART
  • 依托单位:
CSHL 2023 Eukaryotic mRNA Processing Conference
  • 批准号:
    10679367
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2023
  • 负责人:
    DAVID J. STEWART
  • 依托单位:
CSHL 2023 Eukaryotic DNA Replication and Genome Maintenance Conference
  • 批准号:
    10677192
  • 项目类别:
  • 资助金额:
    $1.66万
  • 财政年份:
    2023
  • 负责人:
    DAVID J. STEWART
  • 依托单位:
CSHL 2023 Conference on Biology of Cancer: Microenvironment & Metastasis
  • 批准号:
    10750261
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2023
  • 负责人:
    DAVID J. STEWART
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: